419 related articles for article (PubMed ID: 8915879)
1. Pre-core mutants of hepatitis B virus in patients receiving immunosuppressive treatment after orthotopic liver transplantation.
Protzer U; Goergen B; Hopf U; Neuhaus P; König V; Meyer zum Büschenfelde KH; Gerken G
J Med Virol; 1996 Oct; 50(2):135-44. PubMed ID: 8915879
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
[TBL] [Abstract][Full Text] [Related]
3. Evolution of wild-type and precore mutant HBV infection after liver transplantation.
Torre F; Wong PY; Macartney M; Williams R; Naoumov NV
J Med Virol; 1999 Sep; 59(1):5-13. PubMed ID: 10440801
[TBL] [Abstract][Full Text] [Related]
4. Rare pre-core stop-codon mutant nt. 1897 predominates over wide-spread mutant nt. 1896 in an unusual course of chronic hepatitis B.
Protzer U; Trippler M; Ohl J; Knolle P; Duchmann R; Meyer zum Büschenfelde KH; Gerken G
J Viral Hepat; 1996 May; 3(3):155-62. PubMed ID: 8871875
[TBL] [Abstract][Full Text] [Related]
5. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
[TBL] [Abstract][Full Text] [Related]
6. No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.
Caccamo L; Romeo R; Rossi G; Maggioni M; Radice F; Lunghi G; Colombo M; Fassati LR
Transpl Int; 2005 Feb; 18(2):186-92. PubMed ID: 15691271
[TBL] [Abstract][Full Text] [Related]
7. Semiquantitative assessment of pre-core stop-codon mutant and wildtype hepatitis B virus during the course of chronic hepatitis B using a new PCR-based assay.
Protzer-Knolle U; Knolle P; Schiedhelm E; Meyer zum Büschenfelde KH; Gerken G
Arch Virol; 1996; 141(11):2091-101. PubMed ID: 8973525
[TBL] [Abstract][Full Text] [Related]
8. Prevention and risk factors of the HBV recurrence after orthotopic liver transplantation: 160 cases follow-up study.
Xie SB; Zhu JY; Ying Z; Zeng LJ; Chao M; Lu MQ
Transplantation; 2010 Oct; 90(7):786-90. PubMed ID: 20703179
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.
Okamoto H; Tsuda F; Akahane Y; Sugai Y; Yoshiba M; Moriyama K; Tanaka T; Miyakawa Y; Mayumi M
J Virol; 1994 Dec; 68(12):8102-10. PubMed ID: 7966600
[TBL] [Abstract][Full Text] [Related]
10. [Mutation of hepatitis B virus DNA pre-C region in patients with primary hepatocellular carcinoma in Guangxi].
Fang Z; He B; Zhuang H; Ring L; Harrison TJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Mar; 34(2):83-5. PubMed ID: 11860905
[TBL] [Abstract][Full Text] [Related]
11. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
Günther S; Paulij W; Meisel H; Will H
Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
[TBL] [Abstract][Full Text] [Related]
12. A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxis.
Naumann U; Protzer-Knolle U; Berg T; Leder K; Lobeck H; Bechstein WO; Gerken G; Hopf U; Neuhaus P
Hepatology; 1997 Aug; 26(2):478-84. PubMed ID: 9252162
[TBL] [Abstract][Full Text] [Related]
13. Full-length sequence and functional analysis of hepatitis B virus genome in a virus carrier: a case report suggesting the impact of pre-S and core promoter mutations on the progression of the disease.
Kajiya Y; Hamasaki K; Nakata K; Nakagawa Y; Miyazoe S; Takeda Y; Ohkubo K; Ichikawa T; Nakao K; Kato Y; Eguchi K
J Viral Hepat; 2002 Mar; 9(2):149-56. PubMed ID: 11876799
[TBL] [Abstract][Full Text] [Related]
14. Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation.
Hussain M; Soldevila-Pico C; Emre S; Luketic V; Lok AS;
Liver Transpl; 2007 Aug; 13(8):1137-44. PubMed ID: 17663390
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation.
Rodriguez-Frias F; Buti M; Jardi R; Vargas V; Quer J; Cotrina M; Martell M; Esteban R; Guardia J
Liver; 1999 Jun; 19(3):177-82. PubMed ID: 10395035
[TBL] [Abstract][Full Text] [Related]
16. Clinical course of de novo hepatitis B infection after pediatric liver transplantation.
Su WJ; Ho MC; Ni YH; Wu JF; Jeng YM; Chen HL; Wu YM; Hu RH; Chang MH; Lee PH
Liver Transpl; 2010 Feb; 16(2):215-21. PubMed ID: 20104496
[TBL] [Abstract][Full Text] [Related]
17. Core promoter mutations of hepatitis B virus for the response to interferon in e antigen-positive chronic hepatitis B.
Kanai K; Kako M; Aikawa T; Hino K; Tsubouchi H; Takehira Y; Iwabuchi S; Kawasaki T; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
Am J Gastroenterol; 1996 Oct; 91(10):2150-6. PubMed ID: 8855739
[TBL] [Abstract][Full Text] [Related]
18. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
[TBL] [Abstract][Full Text] [Related]
19. [Detection and characterization of pre-core mutants of hepatitis B virus (HBV) in chronically infected patients].
López JL; Telenta PF; Palacios Poggio González J; Alonso AG; Lemberg A; Campos R
Acta Gastroenterol Latinoam; 1995; 25(2):85-90. PubMed ID: 8525764
[TBL] [Abstract][Full Text] [Related]
20. [HBV C gene mutation in the transmission from father to infant].
Wang SS; Li MM; Peng GF; Li WL; Jin HL; Xiao H; Zeng NH; Wang ZB; Huang JL; Su JX
Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):845-8. PubMed ID: 14728893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
